Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kundan Solanki

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Antiviral Research|February 15, 2023
Nirmatrelvir exerts distinct antiviral potency against different human coronavirusesJiajing Li, Yining Wang, Kundan Solanki, et al.
Virology|October 7, 2021
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronavirusesYining Wang, Pengfei Li, Kundan Solanki, et al.
Vascular Pharmacology|February 7, 2024
Effect of reactive oxygen, nitrogen, and sulfur species on signaling pathways in atherosclerosisKundan Solanki, Evgeny Bezsonov, Alexander Orekhov, et al.
Peerj|July 13, 2022
The expanding roles of neuronal nitric oxide synthase (NOS1)Kundan Solanki, Sajjan Rajpoot, Evgeny E Bezsonov, et al.
Inflammopharmacology|May 1, 2026
Modulating IL-1β-induced pro-atherogenic endothelial responses through drug repurposingKundan Solanki, Sk Rameej Raja, Sunanda Samanta, et al.
Future Virology|August 8, 2022
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterationsKundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, et al.
International Immunopharmacology|April 27, 2023
The indispensability of macrophage adaptor proteins in chronic inflammatory diseasesRajat Atre, Rahul Sharma, Gaponenko Vadim, et al.
International Journal of Peptide Research and Therapeutics|December 20, 2021
In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of ConcernSajjan Rajpoot, Kundan Solanki, Ashutosh Kumar, et al.
Current Research in Structural Biology|December 18, 2023
Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapyKundan Solanki, Ashutosh Kumar, Mohd Shahnawaz Khan, et al.
Archives of Microbiology|September 5, 2022
Anti-lung cancer properties of cyanobacterial bioactive compoundsMirza S Baig, Sajjan Rajpoot, Tomokazu Ohishi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Antiviral Research|February 15, 2023
Nirmatrelvir exerts distinct antiviral potency against different human coronavirusesJiajing Li, Yining Wang, Kundan Solanki, et al.
Virology|October 7, 2021
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronavirusesYining Wang, Pengfei Li, Kundan Solanki, et al.
Vascular Pharmacology|February 7, 2024
Effect of reactive oxygen, nitrogen, and sulfur species on signaling pathways in atherosclerosisKundan Solanki, Evgeny Bezsonov, Alexander Orekhov, et al.
Peerj|July 13, 2022
The expanding roles of neuronal nitric oxide synthase (NOS1)Kundan Solanki, Sajjan Rajpoot, Evgeny E Bezsonov, et al.
Inflammopharmacology|May 1, 2026
Modulating IL-1β-induced pro-atherogenic endothelial responses through drug repurposingKundan Solanki, Sk Rameej Raja, Sunanda Samanta, et al.
Future Virology|August 8, 2022
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterationsKundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, et al.
International Immunopharmacology|April 27, 2023
The indispensability of macrophage adaptor proteins in chronic inflammatory diseasesRajat Atre, Rahul Sharma, Gaponenko Vadim, et al.
International Journal of Peptide Research and Therapeutics|December 20, 2021
In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of ConcernSajjan Rajpoot, Kundan Solanki, Ashutosh Kumar, et al.
Current Research in Structural Biology|December 18, 2023
Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapyKundan Solanki, Ashutosh Kumar, Mohd Shahnawaz Khan, et al.
Archives of Microbiology|September 5, 2022
Anti-lung cancer properties of cyanobacterial bioactive compoundsMirza S Baig, Sajjan Rajpoot, Tomokazu Ohishi, et al.
Pageof 1